New Delhi [India], July 18 (ANI): The All India Institute of Medical Sciences (AIIMS) Ethics Committee on Saturday gave its approval for conducting the human clinical trial of the indigenously developed COVID-19 vaccine candidate Covaxin.
New Delhi [India], July 4 (ANI): The Indian Council of Medical Research (ICMR) on Saturday said that the process to develop an indigenous vaccine to combat COVID-19 is as per globally accepted norms to fast-track the vaccine development.
New Delhi [India], June 30 (ANI): The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited (BBIL) to conduct Phase I and II Human clinical trials to develop an indigenous vaccine for COVID-19 -- in the name COVAXIN.
New Delhi, May 9 [India], May 9 (ANI): The Indian Council of Medical Research (ICMR) on Saturday announced that it has partnered with the Bharat Biotech International Limited (BBIL) to develop a fully indigenous vaccine for COVID-19 using the virus strain isolated at the National Institute o